LexDanaLexDanabeta
Inventor

Hazel Joan Dyke

Inventor
Cambridge, GB

Overview

62→
Patents
1998–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 62 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
A61KPreparations for medical, dental or toiletry purposes17%
Y02ATechnologies for adaptation to climate change5%
C07HSugars2%
A01NPreservation of bodies of humans or animals or plants or parts thereof2%
A61LMethods or apparatus for sterilising materials or objects in general2%
C07BGeneral methods of organic chemistry1%
C07CAcyclic or carbocyclic compounds1%
PatentTitleYear
10,493,071Use of pyrroloquinoline compounds to kill clinically latent microorganisms20199,868,717'Tricyclic sulphonamide compounds and methods of making and using same'20189,839,623'Tricyclic compounds and methods of making and using same'20179,834,5493,3-disubstituted-(8-aza-bicyclo[3.2.1]OCT-8-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanones as inhibitors of 11 (b)-HSD120179,694,006'Use of pyrroloquinoline compounds to kill clinically latent microorganisms'20179,617,237'Partially saturated tricyclic compounds and methods of making and using same'20179,561,230'Aryl-substituted tricyclic sulfonamides as methionyl aminopeptidase 2 modulators'20179,440,943'Tricyclic sulfone compounds and methods of making and using same'20169,440,976'1,7-diazacarbazoles and methods of use'20169,365,564'3,3-disubstituted-(8-aza-bicyclo[3.2.1]oct-8-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanones as inhibitors of 11 (β)-HSD1'20169,359,369'Tricyclic sulfonamide compounds and methods of making and using same'20169,321,740'Tetrazole compounds and methods of making and using same'20169,290,472'Partially saturated tricyclic compounds and methods of making and using same'20169,266,896'Tricyclic compounds and methods of making and using same'20169,242,997'Tricyclic pyrazole sulphonamide compunds and methods of making and using same'20169,221,787'Sulphonamine compounds and methods of making and using same'20159,216,980'Methods of use of diazacarbazoles for treating cancer'20159,187,494'Aryl-substituted tricyclic sulfonamides as methionyl aminopeptidase 2 modulators'20159,067,905'Sulphone compounds and methods of making and using same'20158,759,348'Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms'20148,642,621'(4-phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds and their use'20148,614,209'Amido-thiophene compounds and their use'20138,546,376'Pharmaceutical compounds'20138,501,765'Diazacarbazoles and methods of use'20138,461,328'Tricyclic heterocyclic compounds, compositions and methods of use thereof'20138,362,008'Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors'20138,299,063'Amido-thiophene compounds and their use'20128,258,152'N-substituted azaindoles and methods of use'20128,207,187'Use of pyrroloquinoline compounds to kill clinically latent microorganisms'20128,193,183'2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists'20127,893,085'Aza-benzothiophenyl compounds and methods of use'20117,855,216'Aza-indolyl compounds and methods of use'20107,015,234'Hydroxamic acid derivatives'20066,933,306'Hydroxamic and carboxylic acid derivatives'20056,809,100'Hydroxamic acid derivatives'20046,787,536'Hydroxamic acid derivatives'20046,734,189'Hydroxamic and carboxylic acid derivatives'20046,677,316'Adenosine derivatives and methods of administration'20046,642,254'Heterocyclic compounds and their therapeutic use'20036,610,665'2-(purin-9-yl)-tetrahydrofuran-3, 4-diol derivatives'20036,534,486'2-(purin-9-yl)-Tetrahydrofuran-3,4-diol derivatives'20036,506,773'Hydroxamic and carboxylic acid derivatives'20036,492,348'Adenosine derivatives'20026,469,020'Hydroxamic and carboxylic acid derivatives'20026,455,561'Heterocyclic compounds and their therapeutic use'20026,410,559'Heterocyclic compounds and their therapeutic use'20026,403,791'Heterocyclic compounds and their therapeutic use'20026,353,010'Bicyclic aryl carboxamides and their therapeutic use'20026,331,556'Heterocyclic compounds and their therapeutic use'20016,313,116'Benzothiazole compounds and their therapeutic use'20016,262,070'Heterocyclic compounds and their therapeutic use'20016,169,090'Heterocyclic compounds and their therapeutic use'20016,069,151'Quinolines and their therapeutic use'20006,066,657'Benzofuran-4-carboxamides and their therapeutic use'20005,972,936'Benzofuran carboxamides and their therapeutic use'19995,925,636'Benzofuran carboxamides and their therapeutic use'19995,919,789'Xanthines and their therapeutic use'19995,834,485'Quinoline sulfonamides and their therapeutic use'19985,804,588'Quinoline carboxanides and their therapeutic use'19985,773,467'Benzofuran sulphonanmides'19985,753,666'Quinolones and their therapeutic use'19985,728,712'3,4-disubstituted-phenylsulphonamides and their therapeutic use'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1998–2005Based in Cambridge, GB· patent location history
1999–2005Patents assigned to DARWIN DISCOVERY LTD (19)· patent assignee history
2006Based in Hempstead, GB· patent location history
2010–2018Based in Harlow, GB· patent location history
2012–2017Patents assigned to DYKE HAZEL JOAN (18)· patent assignee history
2012–2017Patents assigned to PALLIN THOMAS DAVID (14)· patent assignee history
2012–2019Based in Essex, GB· patent location history
2013–2017Based in Storrington, GB· patent location history
2014–2016Patents assigned to CRAMP SUSAN MARY (7)· patent assignee history
2015–2018Patents assigned to ZAFGEN INC (13)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
DARWIN DISCOVERY LTD191999–2005
DYKE HAZEL JOANself182012–2017
PALLIN THOMAS DAVID142012–2017
ZAFGEN INC132015–2018
CRAMP SUSAN MARY72014–2016
Locations
LocationPatentsSpan
Cambridge, GB291998–2005
Harlow, GB262010–2018
Essex, GB32012–2019
Storrington, GB32013–2017
Hempstead, GB12006